Tumor necrosis factor-α-induced protein 1 and immunity to hepatitis B virus by Luk, JM et al.
Title Tumor necrosis factor-α-induced protein 1 and immunity tohepatitis B virus
Author(s) Lin, MC; Lee, NP; Zheng, N; Yang, PH; Wong, OG; Kung, HF; Hui,CK; Luk, JM; Lau, GKK
Citation World Journal Of Gastroenterology, 2005, v. 11 n. 48, p. 7564-7568
Issued Date 2005
URL http://hdl.handle.net/10722/167999
Rights Creative Commons: Attribution 3.0 Hong Kong License
PO Box 2345, Beijing 100023, China                                                                                                                                     World J Gastroenterol  2005;11(48):7564-7568
www.wjgnet.com                                                                                                                                                     World Journal of Gastroenterology ISSN 1007-9327
wjg@wjgnet.com                                                                                                                                         © 2005 The WJG Press and Elsevier Inc. All rights reserved.E L S E V I E R
• VIRAL HEPATITIS •
Marie C Lin,  Pai-Hao Yang, Oscar G Wong, Hsiang-Fu Kung, 
Institute of Molecular Biology, The University of Hong Kong, 
Hong Kong SAR, China 
Nikki P Lee, John M Luk, Department of Surgery, The University 
of Hong Kong, Hong Kong SAR, China
Nikki P Lee, John M Luk, George Ka-Kit Lau, Center for the 
Study of Liver Diseases, The University of Hong Kong, Hong 
Kong SAR, China
Ning Zheng, Chee-Kin Hui, George Ka-Kit Lau, Department of 
Medicine, The University of Hong Kong, Hong Kong SAR, China
Correspondence to: George KK Lau, M.D. , Department of 
Medicine Rm 1838, Queen Mary Hospital 102 Pokfulum Road, 
Hong Kong SAR, China. gkklau@netvigator.com
Fax: +852-28184030
Received: 2004-10-06      Accepted: 2005-01-05
Abstract
AIM: To compare the gene expression profile in a pair of 
HBV-infected twins. 
METHODS: The gene expression profile was compared 
in a pair of HBV-infected twins.
RESULTS: The twins displayed different disease 
outcomes. One acquired natural immunity against HBV, 
whereas the other became a chronic HBV carrier. Eighty-
eight and forty-six genes were found to be up- or down-
regulated in their PBMCs, respectively. Tumor necrosis 
factor-alpha-induced protein 1 (TNF-αIP1) that expressed 
at a higher level in the HBV-immune twins was identified 
and four pairs of siblings with HBV immunity by RT-
PCR. However, upon HBV core antigen stimulation, 
TNF-αIP1 was downregulated in PBMCs from subjects 
with immunity, whereas it was slightly upregulated in 
HBV carriers. Bioinformatics analysis revealed a K+ 
channel tetramerization domain in TNF-αIP1 that shares 
a significant homology with some human, mouse, and C 
elegan proteins. 
CONCLUSION: TNF-αIP1 may play a role in the innate 
immunity against HBV. 
© 2005 The WJG  Press and  Elsevier  Inc.  All rights  reserved.
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INTRODUCTION
Though substant ia l advances have been made in 
understanding of  the pathogenesis of  hepatitis B virus 
(HBV), HBV infection remains a global health threat with 
currently more than 350 million carriers and causes about 
one million deaths worldwide. The situation is particularly 
severe in high-endemic areas like southeastern Asia. For 
instance, a study of  16 334 subjects in 1978-1979 in Hong 
Kong suggested that 43% of  the local population have 
evidence of  past infection and 10% are HBs Ag carriers[1].
    The major spread mode of  HBV in most high 
endemic areas, such as Hong Kong and China, is perinatal 
transmission, which accounts for 40%-50% of  chronic 
HBV infection[2,3]. The reason for the preponderance of  
perinatal transmission among Orientals is at least in part 
related to the high prevalence of  HBV infection among 
the Asian carriers of  reproductive age[2]. Though the 
incidence of  perinatal transmission is high in China, not 
all siblings in the same family with HBV-infected mothers 
remain persistently infected with HBV as some acquired 
natural immunity against the virus. We are among the first 
group to demonstrate that the use of  HLA-matched donor 
marrow from siblings with natural immunity could enable 
serological clearance of  HBV in their HBsAg positive 
recipient siblings[4-7]. This indicates that the transfer of  
certain molecules from the donor’s immune system is 
sufficient to confer the recipient immunity against HBV. 
However, the identities of  these molecules are unknown. 
    In this study, Affymetrix cDNA mircroarray was 
employed to investigate the differential gene expression 
patterns in PBMCs in an identical twin pair who had 
different outcomes to HBV infection. Use of  the twin 
pair could eliminate the potential confounding factors 
like age, gender, and living environment, etc. A novel 
cytokine signaling-related gene, TNF-αIP1, is significantly 
downregulated in chronic HBV carriers. Moreover, we 
have confirmed that this gene is indeed differentially 
expressed in several groups of  HBV-infected siblings who 
display different disease outcomes by reverse transcription-
polymerase chain reaction (RT-PCR). We also found that 
upon HBcAg stimulation, TNF-αIP1 exhibited different 
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responses between PBMC isolated from subjects with 
immunity and chronic infection. These results suggest 
that TNF-αIP1 may be involved in immunity against 
HBV infection. An understanding of  the immunological 
and genetic differences in PBMCs of  these sibling pairs 
should provide insight into the molecular mechanisms 
of  the protection and enable a more rationale design of  
therapeutic regimen for chronic HBV infection in Chinese. 
MATERIALS AND METHODS
Patient sample information
Eight groups of  HLA-A, B and DR identical Chinese 
siblings (including pair of  identical twins) who differed 
in their outcomes to HBV infection were used in this 
study. RNA was isolated from PBMC of  the siblings with 
spontaneous recovery (anti-HBs and anti-HBc positive) 
and their corresponding HLA-matched HBV-infected 
siblings (HBsAg positive).
PBMC preparation, RNA extraction, and labeling
Heparinized venous blood was collected and PBMC 
was separated by density-gradient centrifugation over 
Ficoll-Hypaque. Total RNA was extracted from PBMC 
using RNeasy kit (Qiagen, Valencia, CA, USA) following 
manufacturer’s instructions. For each sample, 60 mg of  
total RNA was reverse transcribed using Superscript 
II (Invitrogen, Carlsbad, CA, USA) according to 
manufacturer’s instructions.
DNA microarray
Generation of  antisense RNA (aRNA) probe for cDNA 
microarray analysis was carried out as described previously[8]. 
Briefly, mRNA was amplified using two or three rounds 
of  cDNA synthesis followed by aRNA synthesis. T7-
promoter-oligo-dT [5’-GCCAGTGAATTGTAATAC 
GACTCACTATAGGGAGGCGG-(dT)24-3’] was used for 
cDNA synthesis and T7 RNA polymerase was used for 
aRNA synthesis. Ten micrograms of  starting total RNA 
was used to obtain 10 mg of  final aRNA. During the 
process of  the final aRNA synthesis, biotinylated UTP and 
CTP were used for labeling purpose (Enzo, Farmingdale, 
NY, USA). Detection of  the hybridized probe using 
streptavidin-phycoerythrin fluorescent conjugate was done 
according to manufacturer’s protocol (Molecular Probes, 
Eugene, OR, USA).
    The labeled aRNA probe from PBMC was hybridized 
to a HU 95A gene chip representing 12 000 full-length 
human genes (Affymetrix, Santa Clara, CA, USA). The 
threshold for significant up- or down-regulation was 2.0- 
and 0.5-fold, respectively. Hybridizations were typically 
carried out for 16 h at 45 ℃ followed by washing, staining 
and using Affymetrix fluidic stations. Stained arrays were 
scanned in the G2500 A Hewlett-Packard Gene Array 
Scanner (Hewlett-Packard, Palo Alto, CA, USA) at the 
excitation wavelength of  488 nm. The amount of  emitted 
light was proportional to the bound target at each location 
on the probe arrays.
RT-PCR
Total RNA was reverse transcribed using the Superscript II 
(Invitrogen) according to the manufacturer’s instructions. 
PCR conditions for pre-B-cell colony-enhancing factor 
(PBEF), IL-18 receptor accessory protein (IL-18 RAP), 
TNF-αIP1 and GADPH were as follows: at 94 ℃ for 30 s, 
at 57 ℃ for 30 s, at 72 ℃ for 1 min for 35, 35, 35, and 32 
cycles, respectively. The primer sequences of  the genes 
tested were PBEF (sense: 5’-AAAAGCTGTTCCTGAGG
GCTTTG-3’; anti-sense: 5’-TGACCACAGATACAGGCA
CTGATG-3’); IL-18RAP (sense 5’-CCAGAGCCACAGA
AATCACATTTC-3’; anti-sense 5’-CAAGAAATAGAGCC
AGTGCTCCCA-3’); TNF-αIP1 (sense: 5’- TTACCTCCG
AGATGACACCATCAC-3’; anti-sense: 5’-TCCTCATCTT
CACTGGGGGAA-3’). 
RESULTS AND DISCUSSION
Perinatal transmission is the most common spread mode 
of  hepatitis B infection in Chinese. Yet not all the siblings 
infected with HBV from mothers become chronic HBV 
carriers. It appears that different disease outcomes of  these 
siblings represent success and failure of  their immune 
systems in controlling HBV infection. In this study, we 
attempted to explore this phenomenon by investigating 
gene expression profiles in PBMCs of  two identical twins 
who displayed diverse disease outcomes.
    The differences in PBMC gene expression between two 
identical twins were analyzed using a DNA microarray 
chip containing 12 000 human expressed genes. Eighty-
eight genes were expressed at a higher level and 46 genes 
were expressed at a lower level in twins with immunity 
(HBV resistant) compared to the HBV carrier twins [HBV 
susceptible). These genes were grouped on the basis of  
their predicted functions into 12 major groups (metabolism, 
cell signaling, transcription, transport physiology, growth, 
and differentiation, immune system, cell adhesion, house 
keeping, cell cycle, translation, apoptosis, and unknown 
genes (ESTs)] (Figure 1). We found that genes with 
unknown functions represented the major portion of  
genes with altered expression levels in the HBV immune 
twin.
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Figure 1 Number of genes upregulated or downregulated in the immune 
twin compared to the HBV carrier twin. PBMCs from two HBV infected twins 
with different disease outcomes were analyzed for gene expression using 
DNA microarray. Eighty-eight genes were identified as upregulated and 46 
downregulated. They were further divided into 12 groups based on their presumed 
functions.
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      We are interested in the immune system-related genes 
that are putative candidates for conferring HBV immunity. 
Among the up- or down-regulated genes, eight genes were 
related to immune responses including several cytokine/
chemokine signaling-related genes (Table 1). Three genes, 
namely cytokine PBEF, interleukin IL-18 receptor (R) 
accessory protein and TNF-αIP1 were upregulated in the 
immunity twin. PBEF is a cytokine transcribed in human 
bone marrow, liver tissue and muscle[9,10] and synergized 
with stem cell factor (SCF) and IL-7 activating pre-B-cell 
colony formation[11]. IL-18R accessory protein enhances 
the IL-18 binding activity of  IL-18R1 and is required for 
the activation of  nuclear factor-kappa B (NF-ĸB) and 
mitogen-activated protein kinase 8 (MAPK 8) in response 
to IL-18. TNF-αIP1 is first identified as a primary response 
gene in human umbilical vein endothelial cells towards 
TNF-α stimulation[12], but yet with no known function.
    Five genes were downregulated in the HBV-immuned 
twins. They are the signal transducer and activator of  
transcription 5b (Stat5b), which is crucial for normal 
immune function and T-cell-mediated mitogenic signals 
Table 1 Differential expression of immunity-related genes in PBMCs of HBV identical twin patients
UniGene ID                                           Gene name                                          Known function(s)                                                    Fold change
Hs.244613                                       Signal transducer                                      Signal transducer of  IL-2, IL-4,                                                             –4.2
                                                             and activator of                                      CSF1, and different growth hormones.
                                                                transcription                                        I mportant for TCR signaling,  apoptosis, 
                                                                5b (STAT 5b)                                        adult mammary  gland development, and  
                                                                                                                               sexual dimorphism of liver gene expression                                                                       
Hs.239138                                Pre-B-cell colony-enhancing                          A cytokine that increases the expression of
                                                              factor (PBEF)                         IL-6 and IL-8 in fetal membrane and may be                                       2.2
                                                                    important in both normal spontaneous labor 
                                                                                                                                and infection-induced preterm labor
Hs.158315                             Interleukin 18 receptor accessory    An accessory subunit of the heterodimeric  
                                                            protein (IL-18RAP)                                 receptor for IL-18 enhances the IL-18 binding                                     3.0
                                                                                                                               a ligand binding subunit of IL-18 receptor.
                                                                                                                               The coexpression of IL-18R1 and  this protein 
                                                                                                                               is required for the activation of NF-κB and   
                                                                                                                                MAPK8 (JNK) in response to IL-18
   
Hs.76090                        Tumor necrosis factor-alpha-induced      Unknown                                                                                2.3
                                             protein 1 (endothelial) (TNF-αIP1)
   
Hs.225948                         Chemokine (C-C motif)                                         Cytokine that plays a role in mediatinghoming 
                                              ligand 27 (CCL27)                                                 of lymphocytes to cutaneous sites. It specifically                   -2.5
                                                                                                                                binds to chemokine receptor 10 (CCR10). Studies of 
                                                                                                                               murine protein indicate that these protein-receptor 
                                                                                                                               interactions have a pivotal role in T-cell-mediated skin inflammation 
Hs.301921                  C-C chemokine receptor type 1 (C-C CKR-1)     Cytokine receptor important for host 
                                                                                                                               protection from inflammatory response                                       -2.7
                                                                                                                               and susceptibility to virus and parasite
  
Hs.57735                 Scavenger receptor class F, member 1 (SCARF1)       Scavenger receptor that has roles in the binding  
                                                                                                                                and degradation of acetylated low density lipoprotein                  -2.2
                                                                                                                                and may be involved in atherosclerosis 
Hs.4930                 Low density lipoprotein receptor-related      A membrane protein which may be involved                   -2.8
                                                 protein 4 (LRP4)                                                  in calcium ion binding
and is a key signal transducer of  T-cell receptor[13]. The 
chemokine (C-C motif) ligand 27 (CCL27) and C-C 
chemokine receptor type 1 (C-C CKR-1) are important 
for host inf lammatory response. We also observed 
the downregulation of  the scavenger receptor class 
F member 1 (SCARF1) and low-density lipoprotein 
receptor-related protein 4. Scavenger receptors encompass 
a broad range of  molecules involved in receptor-mediated 
endocytosis of  selected polyanionic ligands, including 
modified low-density lipoproteins (LDL)[14]. Further 
investigating the role of  these genes and the molecular 
differences between immune siblings and HBV chronic 
carrier siblings may help us in designing therapeutic 
measures that modulate the immune system of  patients in 
controlling HBV infection.
    Of  the eight immune system-related genes, TNF-
αIP1 demonstrated the highest frequency of  differential 
expression among the other groups of  HBV-infected 
HLA-matched siblings with different disease outcomes as 
determined by semi-quantitative RT-PCR (Figure 2A). As 
shown in Figure 2B, the expression level of  TNF-αIP1 was 
1Fold changes between the HBV immune twin pair. Positive number indicates upregulation, whereas negative number denotes downregulation.
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Figure 2 Expression levels of TNF-αIP1 gene in HBV-infected siblings with 
different disease outcomes. A: RT-PCR analysis of TNF-αIP1 in four sibling pairs; B: 
Fold changes of band intensity of TNF-αIP1 in different sibling groups. Open bar: 
HBV immune patients; black or patterned bars: HBV carrier; S1: sibling group 1; 
S2: sibling group 2; S3: sibling group 3; S4: sibling group 4.
lower in HBV carriers than in their HBV immune siblings 
in two siblings groups. Noticeably, the expression of  TNF-
αIP1 was significantly downregulated in HBV carrier 
siblings of  group 3 and all four carrier siblings displayed 
down-regulation of  TNF-αIP1. Suggesting that TNF-αIP1 
may be a gene differentially expressed in PBMCs of  HBV 
immune and carrier patients.
    Recent studies suggest that cytokine response plays an 
important role in successful host defense against HBV 
infection. In transgenic mouse and chimpanzee model, 
cytotoxic T lymphocytes do not directly kill HBV-infected 
hepatocytes, but inhibit the viral replication through the 
actions of  TNF-α and interferon (IFN-γ)[15,16]. Romero 
and Lavine[17] demonstrated that TNF-α and IFNs can 
downregulate the activity of  HBV core/pregenomic 
(C/P) promoter, hence contributing to viral clearance. 
Moreover, activated intrahepatic antigen-presenting cells 
can inhibit liver HBV replication by secreting IL-12 and 
TNF-α[18]. One of  the downstream mechanisms of  how 
TNF-α modulates HBV infection is via the activation of  
NF-ĸB, which can inhibit HBV replication[19]. Interestingly, 
we have shown that TNF-αIP1 (a TNF-α inducible gene) 
expresses at a higher level in HBV immunized twin. 
TNF-αIP1 was first identified as an endothelial primary 
response gene towards TNF-α (then named B12), which 
induces TNF-αIP1 expression rapidly and transiently. 
Biochemical characterization suggests that TNF-αIP1 
is a 36 ku protein, which may play a regulatory role and 
locate intracellularly[12]. The role of  TNF-αIP1 in TNF-α-
mediated NF-κB activation and HBV replication inhibition 
is of  interest for further study.
    Phylogenetic analysis showed that TNF-αIP1 could 
evolve into human and mouse endothelial protein 1 
(Edp1), reflecting the fact that Edp1 is likely the mouse 
ortholog of  TNF-αIP1 (Figure 3A). Predicted from the 
Figure 3 TNF-αIP1 shares significant homology with some human, mouse, and 
C elegan proteins, having common K+ channel tetramerization/POZ domain. A: 
Phylogenetic analysis of evolutionary distance of the protein sequences. The 
protein sequences were analyzed by the Growtree program provided by the GCG 
package. Kimura distance was adopted as the distance correction method. B: 
Amino acid sequence alignment of TNF-αIP1 (A41784) with mouse Edp1 protein 
(AAC78826), human MSTP028 protein (NP_114160), PDIP1 (AAL14962), human 
REN protein (XP_208568), and four C elegan K+ channel family members and 
with highest homology to TNF-αIP1 (NP_499312, NP_494320, NP_494476 and 
NP_494315). Black line: K+ channel tetramerization/POZ domain. 
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B
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amino acid sequence of  TNF-αIP1 (A41784), there is a 
K+ channel tetramerization domain in the middle of  the 
sequence. This N-terminal, cytoplasmic tetramerization 
domain (T1) of  voltage-gated K+ channels encodes 
molecular determinants for subfamily-specific assembly 
of  alpha-subunits into functional tetrameric channels[20]. It 
is distantly related to the BTB/POZ domain which plays 
an oligomerization role in the function of  this protein. 
Interestingly, the K+ channel tetramerization domain 
is the common domain feature shared by many TNF-α 
inducible proteins. For instance, mouse TNF-α inducible 
proteins such as Edp1 share high homology with the entire 
amino acid sequence of  TNF-αIP1 (97% identity) (Figures 
3A and B). It is also noticed that there was a group of  C 
elegan proteins containing the K+ channel tetramerization 
domain. However, the function of  this group of  proteins 
is unknown.
     Among the prote ins conta in ing K+ channel 
tetramerization domain, polymerase delta-interacting 
protein 1 (PDIP1) is best characterized[21]. PDIP1 is 
a TNF-α inducible protein and plays a role in linking 
cytokine activation and DNA replication in the liver as 
well as in other tissues. It localizes inside the nuclei and 
interacts with DNA polymerase δ small subunit (p50) and 
proliferating cell nuclear antigen (PCNA). In addition, 
it modulates DNA polymerase δ activity in a PCNA 
dependent manner. Importantly, it shares high homology 
(62% identity) with TNF-αIP1 (B12). PDIP1 is involved in 
TNF-α-mediated hepatocyte regeneration and stimulates 
hepatocyte proliferation upon TNF-α signal[21]. It is of  
interest to know whether this is also true for TNF-αIP1 
using cell proliferation assay.    
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